頭頸癌診斷市場 - 全球行業規模、份額、趨勢、機遇和預測，2017-2027 年：按類型、成像、活檢、內窺鏡、牙科診斷、最終用戶、地區

在 2023 年至 2027 年的預測期內，全球頭頸癌診斷市場預計將以驚人的複合年增長率增長。

人口老齡化加劇，容易患癌症等多種慢性病，這正在推動全球頭頸癌診斷市場的增長。

癌症發病率上升推動市場增長

癌症是指細胞不受控制的異常生長，形成稱為癌性或良性腫瘤的腫塊。 特別是在工作人群中，久坐不動的生活方式會導致包括癌症在內的多種慢性疾病。 此外，越來越多的老年人由於免疫系統減弱而更容易患上慢性病，這進一步推動了全球頭頸癌診斷市場的增長。 根據美國國家生物技術信息中心的一項研究，頭頸癌是世界上第六大常見癌症。 經常吸煙和過度飲酒也被證明會增加消費者患頭頸癌的風險。

對診斷成像設備不斷增長的需求推動了市場增長

醫學成像是指用於醫學乾預的身體內部可視化表示、器官和組織功能的可視化表示以及器官臨床分析的技術和程序。 頭頸癌是指一組起源於鱗狀上皮的癌症，鱗狀上皮通常分佈在口腔、鼻子、頸部和喉嚨。 頭部MRI、鼻竇CT、頭部CT、臨床分析、全景牙科X光、牙科錐形束CT、PET/CT來檢測這些癌症的精確位置並確定有無轉移，以及胸部影像學是一些對患者進行的常見診斷程序。

對有效靶向治療的需求不斷增長推動市場增長

對於許多腫瘤學家來說，治療頭頸癌是一項艱鉅的任務。 治療的可行性和選擇取決於癌症的部位以及患者。 面部的複雜結構使頭頸癌的手術治療變得複雜，使手術成為醫療專業人員的首選治療方式。 Oncosurgery 傾向於結合手術和放療來治療頭頸癌。 準確診斷以分析癌症的嚴重程度對於手術後獲得更好的結果起著重要作用。 基因療法、抗體-藥物偶聯物和單克隆抗體等靶向分子療法的引入為全球頭頸癌診斷市場提供了潛在途徑。

可自定義

TechSci Research 根據市場數據提供定制服務，以滿足貴公司的獨特需求。 該報告可以定制為：

公司信息

• 對其他市場公司（最多 5 家公司）進行深入分析和概況分析。

內容

第 1 章產品類型概述

第二章研究方法論

第 3 章 COVID-19 對全球頭頸癌診斷市場的影響

第四章客戶反饋

第 5 章執行摘要

第 6 章頭頸癌診斷的全球市場展望

• 市場規模和預測
  • 按金額
• 市場份額和預測
  • 按類型（診斷成像、活檢、內窺鏡、牙科診斷劑）
  • 最終用戶（醫院、專科診所、門診手術中心、其他）
  • 按公司分類（2021 年）
  • 按地區
• 產品市場地圖

第 7 章北美頭頸癌診斷市場展望

• 市場規模和預測
  • 按金額
• 市場份額和預測
  • 按類型（診斷成像、活檢、內窺鏡、牙科診斷劑）
  • 最終用戶（醫院、專科診所、門診手術中心、其他）
  • 按國家
• 北美分析
  • 美國
  • 墨西哥
  • 加拿大

第 8 章：歐洲頭頸癌診斷市場前景

• 市場規模和預測
  • 按金額
• 市場份額和預測
  • 按類型（診斷成像、活檢、內窺鏡、牙科診斷劑）
  • 最終用戶（醫院、專科診所、門診手術中心、其他）
  • 按國家
• 歐洲國家分析
  • 法國
  • 德國
  • 英國
  • 意大利
  • 西班牙

第 9 章亞太地區頭頸癌診斷市場展望

• 市場規模和預測
  • 按金額
• 市場份額和預測
  • 按類型（診斷成像、活檢、內窺鏡、牙科診斷劑）
  • 最終用戶（醫院、專科診所、門診手術中心、其他）
  • 按國家
• 亞太國家/地區分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳大利亞

第 10 章南美頭頸癌診斷市場前景

• 市場規模和預測
  • 按金額
• 市場份額和預測
  • 按類型（診斷成像、活檢、內窺鏡、牙科診斷劑）
  • 最終用戶（醫院、專科診所、門診手術中心、其他）
  • 按國家
• 南美分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第11章中東和非洲頭頸癌診斷市場前景

• 市場規模和預測
  • 按金額
• 市場份額和預測
  • 按類型（診斷成像、活檢、內窺鏡、牙科診斷劑）
  • 最終用戶（醫院、專科診所、門診手術中心、其他）
  • 按國家
• MEA：國家分析
  • 南非的頭頸癌診斷
  • 沙特阿拉伯的頭頸癌診斷
  • 阿聯酋的頭頸癌診斷

第 12 章市場動態

• 司機
• 任務

第13章市場趨勢與發展新興國家市場趨勢與發展

第14章競爭格局

• Addent Inc
• GE Healthcare
• Koninklijke Philips NV
• Shimadzu Corporation
• Siemens Healthineers AG
• Fujifilm Holdings Corporation
• Canon Medical system Corporation
• Carestream Healthcare Inc.
• Neusoft Medical Systems Co., Ltd.
• Varian Medical Systems, Inc.

第15章 策略建議

The global head and neck cancer diagnostic market is expected to grow at an impressive CAGR in the forecast period, 2023-2027. The increasing geriatric population who are more prone to numerous chronic diseases such as cancer is driving the growth of the global head and neck cancer diagnostic market.

Inflating disposable income leads to increased healthcare expenditure by the people. Furthermore, the escalating demand for diagnostic imaging, advancing treatment modes, and the incorporation of novel technologies in diagnostics equipment by the market players are expected to stimulate market growth. Also, the increased adoption of sedentary lifestyles and modifications in dietary habits is giving rise to several incidences among consumers, which further contributes to the global head and neck cancer diagnostics market growth. The growing need for targeted therapies and the awareness among the people regarding the availability and effectiveness of several oncological treatment procedures are expected to influence the global head and neck cancer diagnostic market growth in the forecast period.

Increasing Incidences of Cancer Propels the Market Growth

Cancer refers to the uncontrolled and abnormal growth of cells that form a mass known as a tumor that can be cancerous or benign. The adoption of sedentary lifestyles, especially among the working population, leads to various chronic illnesses, including cancer. The growing old age population who are more prone to any chronic diseases as their immune system gets weak further supports the growth of the global head and neck cancer diagnostics market. As per a study by the National Center for Biotechnology Information, head and neck cancer is considered the sixth-most common cancer globally. Regular consumption of tobacco and excessive alcohol consumption also increases the risk of head and neck cancer in consumers.

Rise In Demand for Diagnostic Imaging Equipment Fuels the Market Growth

Diagnostic imaging refers to the technique and procedure of creating visual representations of the interior of a body for medical intervention, visual representation of the function of some organs or tissues, and clinical analysis of any organ. Head and neck cancer refers to the group of cancers that generally begins in the squamous cells that line the mouth, nose, neck, and throat. To detect the accurate location of these kinds of cancer and determine if it has spread, head MRI, CT of the sinuses, head CT, clinical analysis and panoramic dental x-ray, dental cone beam CT, PET/CT, or chest imaging are a few of the common diagnostic procedures which are performed upon the patients.

Elevating Need for Effective Targeted Treatment Boosts the Market Growth

Treatment for head and neck cancer is a challenging task for many oncologists. Treatment availability and choice depend upon the location of cancer and vary from patient to patient. Due to the facial structure's complexity, the surgical treatments for head and neck cancers become complex, with surgery being the preferred mode of treatment mode among healthcare professionals. Onco-surgeon prefers surgical therapy in combination with radiation therapy for head and neck cancer treatment. For better results after surgery, accurate diagnosis plays a significant role in analyzing the cancer severity. The introduction of targeted molecular therapy, including gene therapy, antibody-drug conjugates, and monoclonal antibodies, offers a potential avenue for the global head and neck cancer diagnostics market.

Market Segmentation

The global head and neck cancer diagnostics market is segmented into type, end user, regional distribution, and competitive landscape. Based on the type, the market is divided into diagnostic imaging, biopsy, endoscopy, and dental diagnostics. Diagnostic imaging is further divided into PET/CT, MRI, X-Ray, and others and biopsy is divided into incisional biopsy, fine needle aspiration biopsy, and HPV testing. Similarly, endoscopy is divided into pharyngoscopy, laryngoscopy, and pan endoscopy, and dental diagnostics is divided into brush biopsy, fluorescence visualization, acetic acid rinse method, and toluidine blue dye-based met. Based on the end user, the market is divided into hospitals, specialty clinics, ambulatory surgical centers, and others. The market analysis also studies the regional segmentation, divided among the North American region, the Asia-Pacific region, the European region, the South American region, and the Middle East & African region.

Market Players

Addent Inc, GE Healthcare, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon Medical System Corporation, Carestream Healthcare Inc., Neusoft Medical Systems Co., Ltd., Varian Medical Systems, Inc. are the key market players leading the growth of the global head and neck cancer diagnostics market.

Report Scope

In this report, global head and neck cancer diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Head and Neck Cancer Diagnostics Market, By Type:

• Diagnostic Imaging
  • PET/CT
  • MRI
  • X-Ray
  • Others

• Biopsy
  • Incisional Biopsy
  • Fine Needle Aspiration Biopsy
  • HPV Testing

• Endoscopy
  • Pharyngoscopy
  • Laryngoscopy
  • Panendoscopy

• Dental Diagnostics
  • Brush Biopsy
  • Fluorescence Visualization
  • Acetic Acid Rinse Method
  • Toluidine Blue Dye-Based Method
  • Head and Neck Cancer Diagnostics Market, By End-User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

Head and Neck Cancer Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain

• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global head and neck cancer diagnostics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Type Overview

2. Research Methodology

3. Impact of COVID-19 on Global Head and Neck Cancer Diagnostics Market

4. Voice of Customer

5. Executive Summary

6. Global Head and Neck Cancer Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 6.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 6.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 6.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 6.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 6.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 6.2.3. By Company (2021)
  • 6.2.4. By Region
• 6.3. Product Market Map

7. North America Head and Neck Cancer Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 7.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 7.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 7.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 7.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 7.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Head and Neck Cancer Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Mexico Head and Neck Cancer Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Canada Head and Neck Cancer Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User

8. Europe Head and Neck Cancer Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 8.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 8.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 8.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 8.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 8.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 8.2.3. By Country
• 8.3. Europe: Country Analysis
  • 8.3.1. France Head and Neck Cancer Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Germany Head and Neck Cancer Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. United Kingdom Head and Neck Cancer Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. Italy Head and Neck Cancer Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Spain Head and Neck Cancer Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. Asia-Pacific Head and Neck Cancer Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 9.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 9.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 9.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 9.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 9.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 9.2.3. By Country
• 9.3. Asia-Pacific: Country Analysis
  • 9.3.1. China Head and Neck Cancer Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. India Head and Neck Cancer Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Japan Head and Neck Cancer Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User
  • 9.3.4. South Korea Head and Neck Cancer Diagnostics Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By End User
  • 9.3.5. Australia Head and Neck Cancer Diagnostics Market Outlook
    • 9.3.5.1. Market Size & Forecast
      • 9.3.5.1.1. By Value
    • 9.3.5.2. Market Share & Forecast
      • 9.3.5.2.1. By Type
      • 9.3.5.2.2. By End User

10. South America Head and Neck Cancer Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 10.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 10.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 10.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 10.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 10.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Head and Neck Cancer Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Argentina Head and Neck Cancer Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. Colombia Head and Neck Cancer Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Middle East and Africa Head and Neck Cancer Diagnostics Market Outlook

• 11.1. Market Size & Forecast
  • 11.1.1. By Value
• 11.2. Market Share & Forecast
  • 11.2.1. By Type (Diagnostic Imaging, Biopsy, Endoscopy, Dental Diagnostics)
    • 11.2.1.1. By Diagnostic Imaging (PET/CT, MRI, X-Ray, Others)
    • 11.2.1.2. By Biopsy (Incisional Biopsy, Fine Needle Aspiration Biopsy, HPV Testing)
    • 11.2.1.3. By Endoscopy (Pharyngoscopy, Laryngoscopy, Panendoscopy)
    • 11.2.1.4. By Dental Diagnostics (Brush Biopsy, Fluorescence Visualization, Acetic Acid Rinse Method, Toluidine Blue Dye-Based Method)
  • 11.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
  • 11.2.3. By Country
• 11.3. MEA: Country Analysis
  • 11.3.1. South Africa Head and Neck Cancer Diagnostics Market Outlook
    • 11.3.1.1. Market Size & Forecast
      • 11.3.1.1.1. By Value
    • 11.3.1.2. Market Share & Forecast
      • 11.3.1.2.1. By Type
      • 11.3.1.2.2. By End User
  • 11.3.2. Saudi Arabia Head and Neck Cancer Diagnostics Market Outlook
    • 11.3.2.1. Market Size & Forecast
      • 11.3.2.1.1. By Value
    • 11.3.2.2. Market Share & Forecast
      • 11.3.2.2.1. By Type
      • 11.3.2.2.2. By End User
  • 11.3.3. UAE Head and Neck Cancer Diagnostics Market Outlook
    • 11.3.3.1. Market Size & Forecast
      • 11.3.3.1.1. By Value
    • 11.3.3.2. Market Share & Forecast
      • 11.3.3.2.1. By Type
      • 11.3.3.2.2. By End User

12. Market Dynamics

• 12.1. Drivers
• 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

• 14.1. Addent Inc
• 14.2. GE Healthcare
• 14.3. Koninklijke Philips NV
• 14.4. Shimadzu Corporation
• 14.5. Siemens Healthineers AG
• 14.6. Fujifilm Holdings Corporation
• 14.7. Canon Medical system Corporation
• 14.8. Carestream Healthcare Inc.
• 14.9. Neusoft Medical Systems Co., Ltd.
• 14.10. Varian Medical Systems, Inc.

15. Strategic Recommendations